Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter O'Leary

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Heart, Lung & Circulation|April 6, 2010
A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiologyGerald F Watts, Frank M van Bockxmeer, Timothy Bates, et al.
Abdominal Radiology (New York)|October 19, 2017
Epiploic appendagitis: 7-year experience and relationship with visceral obesityJames P Nugent, Hugue A Ouellette, D Peter O'Leary, et al.
The Journal of Clinical Endocrinology and Metabolism|January 26, 2010
Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniquesJohn P Walsh, Alexandra P Bremner, Peter Feddema, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|October 11, 2012
Baseline investigations of folate status in Aboriginal and non-Aboriginal West Australians prior to the introduction of mandatory fortificationSusannah J Maxwell, Kate J Brameld, Caroline Bower, et al.
International Journal of Evidence-Based Healthcare|December 6, 2014
A framework for bridging the gap in the care of familial hypercholesterolaemia in the community: pragmatic and economic perspectivesSharon Purchase, Alistair Vickery, Jacquie Garton-Smith, et al.
Anticancer Research|May 6, 2021
Evaluation of the Cytotoxic Effects of the Novel Antineoplastic Agent 1,4,5-Oxathiazinane-4,4-dioxide on Triple Negative Breast Cancer CellsMarcel Jinih, Jiang Huai Wang, Rolf W Pfirrmann, et al.
Obstetrics and Gynecology|April 4, 2006
First-trimester combined screening for Down syndrome and other fetal anomaliesPeter O'Leary, Nikki Breheny, Jan E Dickinson, et al.
Surgical Oncology|May 20, 2022
Assessment of cell-free DNA (cfDNA) concentrations in the perioperative period can predict risk of recurrence in patients with non-metastatic breast cancerFara Hassan, Jiang Huai Wang, Carolyn Cullinane, et al.
Archives of Internal Medicine|November 30, 2005
Subclinical thyroid dysfunction as a risk factor for cardiovascular diseaseJohn P Walsh, Alexandra P Bremner, Max K Bulsara, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 10, 2009
First trimester predictors of adverse pregnancy outcomesKate J Brameld, Jan E Dickinson, Peter O'Leary, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Heart, Lung & Circulation|April 6, 2010
A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiologyGerald F Watts, Frank M van Bockxmeer, Timothy Bates, et al.
Abdominal Radiology (New York)|October 19, 2017
Epiploic appendagitis: 7-year experience and relationship with visceral obesityJames P Nugent, Hugue A Ouellette, D Peter O'Leary, et al.
The Journal of Clinical Endocrinology and Metabolism|January 26, 2010
Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniquesJohn P Walsh, Alexandra P Bremner, Peter Feddema, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|October 11, 2012
Baseline investigations of folate status in Aboriginal and non-Aboriginal West Australians prior to the introduction of mandatory fortificationSusannah J Maxwell, Kate J Brameld, Caroline Bower, et al.
International Journal of Evidence-Based Healthcare|December 6, 2014
A framework for bridging the gap in the care of familial hypercholesterolaemia in the community: pragmatic and economic perspectivesSharon Purchase, Alistair Vickery, Jacquie Garton-Smith, et al.
Anticancer Research|May 6, 2021
Evaluation of the Cytotoxic Effects of the Novel Antineoplastic Agent 1,4,5-Oxathiazinane-4,4-dioxide on Triple Negative Breast Cancer CellsMarcel Jinih, Jiang Huai Wang, Rolf W Pfirrmann, et al.
Obstetrics and Gynecology|April 4, 2006
First-trimester combined screening for Down syndrome and other fetal anomaliesPeter O'Leary, Nikki Breheny, Jan E Dickinson, et al.
Surgical Oncology|May 20, 2022
Assessment of cell-free DNA (cfDNA) concentrations in the perioperative period can predict risk of recurrence in patients with non-metastatic breast cancerFara Hassan, Jiang Huai Wang, Carolyn Cullinane, et al.
Archives of Internal Medicine|November 30, 2005
Subclinical thyroid dysfunction as a risk factor for cardiovascular diseaseJohn P Walsh, Alexandra P Bremner, Max K Bulsara, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 10, 2009
First trimester predictors of adverse pregnancy outcomesKate J Brameld, Jan E Dickinson, Peter O'Leary, et al.
Pageof 12